ASTH stock news · Astrana Health

Stories about Astrana Health (ASTH) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ASTH

Follow Astrana Health (ASTH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 5, 2026, 6:52 PM ET · Market
Astrana Health had a great third quarter, with sales hitting a record $1.02 billion, up 7%.
Good for ASTH
Astrana Health reported $1.02 billion in sales, up 7% year over year, and $77.2 million in adjusted EBITDA, up 13%. Its 2027 adjusted EBITDA growth expectation makes this a positive update.
Sep 23, 2026, 8:14 AM ET · Market
Astrana Health, Inc. shared an updated company presentation for upcoming conferences and meetings.
Neutral
Astrana filed an updated investor presentation in a Form 8-K; this is routine and does not change how I read Astrana today.
Sep 15, 2026, 8:53 AM ET · Market
Astrana Health, Inc. shares new info about its business plans and finances.
Neutral
Astrana filed an 8-K furnishing an investor presentation (Exhibit 99.1). No new financial figures were reported, so this filing does not change how we read ASTH.